Hospital CEO files lawsuit after losing job over naked art exhibition

The former CEO of Robert Wood Johnson University Hospital Hamilton has filed a wrongful termination lawsuit against his former employer, saying his departure stemmed from a nude “living art” body painting exhibit held at a hospital fundraising event. 

According to Richard Freeman's legal complaint, the hospital blamed him for failing to prevent the June 3 exhibit, which featured naked women with artwork painted on their bodies, from taking place at an offsite fundraising event. However, he claims that more than 40 individuals were engaged in the planning and approval process.

NJ.com covered the situation at length, noting that Freeman contends he had no involvement in planning the event. In fact, he has said he was barely aware of it. 

Freeman's lawsuit, filed in federal court in New Jersey, asserts he was dismissed shortly after the event and violated hospital sexual harassment policies. Freeman contests the claim and says his employment was terminated to avoid fulfilling compensation obligations. 

At the time of his termination, Freeman was receiving an annual salary of $650,000, along with performance-based incentives. Freeman claims in the suit that, should the hospital choose to terminate his employment without cause, they are liable for 180 days of his regular compensation in addition to 12 months of severance payments equivalent to his base salary, along with continued medical and dental benefits for the same duration. 

The hospital declined to comment. 

For more context, click the link below:

Chad Van Alstin Health Imaging Health Exec

Chad is an award-winning writer and editor with over 15 years of experience working in media. He has a decade-long professional background in healthcare, working as a writer and in public relations.

Around the web

“Now more than ever, we must recognize that our country’s leadership in groundbreaking medical research spurs scientific innovation, improves public health and creates new innovations that save and improve lives nationwide,” Joseph C. Wu, MD, PhD, explained in a statement. 

The technology used to diagnose, treat and manage cardiovascular disease is always evolving, keeping FDA officials quite busy. But have the agency's standards been slipping in recent years? A cardiologist with Cedars-Sinai Medical Center explored that very question.

No devices need to be returned at this time. However, the FDA warned, using these heart pumps without reviewing the updated instructions could result in "serious injury or death.”